Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
about
Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancerCombined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II studyAdjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer.A phase I and pharmacokinetic study of indisulam in combination with carboplatinA phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.Innovative treatment strategies in locally advanced and/or unresectable non-small cell lung cancer.Successful low-dose concurrent chemotherapy and radiation for locally advanced or inoperable non-small cell lung carcinoma: a report of six cases.Prophylaxis for paclitaxel hypersensitivity reactions.Standards of care for anemia management in oncology: focus on lung carcinoma.Taxanes for advanced non-small cell lung cancer.Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences.A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer.Treatment of non-small cell lung cancer (NSCLC).A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531.Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain.Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial.Carboplatin and paclitaxel for previously treated patients with non-small-cell lung cancer.Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.New Agents in the Management of Non-Small Cell Lung Cancer.A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma.Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer.The efficacy and safety of Padexol (paclitaxel) and cisplatin for treating advanced non-small cell lung cancer.[The clinical analysis of paclitaxel at two dose levels plus carboplatin as the first-line treatment in advanced non-small cell lung cancer].
P2860
Q24642049-CD76BE71-8FB5-41EB-874B-B72C90A3A800Q28364203-7E623862-D214-44FA-9175-448956C9E776Q30438068-6D3E6E9F-4481-4719-98C2-A2A803528D67Q33328423-3990E457-EB4F-442B-B725-0868B4402262Q33333677-65DFC7F3-DF48-43E9-9123-901CF856CEC8Q33341208-03201434-A5AD-4978-83F8-CAEEF339DC6AQ33360013-6C3BB432-2C2E-4984-A8F0-F4301D3B3300Q33374168-F1BA6246-5AF3-4523-BBF9-F4742FF1DBAFQ33426444-C42E10F5-9DB0-4622-927E-E1D966EE65DCQ33497942-9890A73F-16CA-4606-97DE-54D56558E3FCQ33877442-0A090238-DC3C-41CE-93A2-C132AB55980FQ33880276-B2822BA3-D5A9-42CC-8D9B-CE1A4373C4D5Q34382562-C8444931-9752-4B23-A28F-A039814A314CQ34810857-909543C7-D8B0-4974-BB70-A6F36D3F9616Q35020524-2CB3FC27-76FC-41DA-88B3-F1281EBE0CF9Q35096015-F6B02FBC-667E-4884-BBF6-E3B5A9292C03Q35947740-F5FD7F4E-778A-48A7-AF06-07C53C488CBCQ36114656-9E5D399D-A224-43DC-BCFD-CFD2A312CDE2Q36431257-D218725C-1F8E-4E73-A196-A69120AF9491Q36621872-A8C51358-4ACB-4026-BC16-D4B2A5E5079DQ38150348-561EC1BD-F8BE-481F-8DDF-9FA06DC4FE70Q42632289-3D4DB683-6BBD-4E2F-A644-2F246CE9D752Q43680179-94B51438-F55B-4A9B-9ED8-297985039C68Q43707369-4101A2D2-F007-4C1A-A85F-0C471E620F18Q45112739-DE6032DF-406E-42FB-95B0-5C75DF1DE509Q45126932-AB8F45F1-4C18-4A56-879C-2C31EC532C2FQ47620441-564829F8-D9A9-4283-A548-AAE29790A1C8Q48017892-DE89566F-1D08-495F-9F99-D701DC7CB121Q48149220-936EEFF1-F2D5-41B4-B890-B76CABC5B8D9Q50317333-B2E02174-DB8C-4B42-8AA3-D8413E459487Q55456413-1ED5CFFE-38BC-43B6-8C3C-C35EF73EF436
P2860
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@ast
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@en
type
label
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@ast
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@en
prefLabel
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@ast
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@en
P2093
P1476
Paclitaxel and carboplatin in ...... sponse, and survival analysis.
@en
P2093
C A McAleer
C J Langer
J C Leighton
P F Engstrom
P J O'Dwyer
P304
P356
10.1200/JCO.1995.13.8.1860
P407
P577
1995-08-01T00:00:00Z